Hi-Clearance (1788.TWO) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · Taiwan · ISIN TW0001788008

Price
127.00 TWD
Market cap
5.65 bn TWD
P/E (2025)
15.34
P/S (2025)
1.32
Dividend yield
5.51 %
Net margin
8.61 %
Return on equity (ROE)
12.08 %
Return on assets (ROA)
7.25 %

Hi-Clearance financials

Fiscal year20242025
Revenue4.07 bn TWD4.28 bn TWD
Gross profit1.07 bn TWD1.14 bn TWD
Operating income427.87 m TWD421.57 m TWD
EBIT468.88 m TWD473.61 m TWD
Net income359.69 m TWD368.51 m TWD
Diluted EPS – continuing operations8.08 TWD8.28 TWD

Full history since 2015, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

Sign up for freeOpen interactive view

About Hi-Clearance

Hi-Clearance Inc. supplies medical devices for the renal, cardiac, radiation, dentistry, oral surgery, thoracic, respiratory, and metabolism markets in Taiwan. The company offers dialyzers, dialysis and, RO machines, and related consumables and drugs; interventional cardiology and radiology, and plastic surgery devices; dentistry consumables, implant materials, and equipment; and blood glucose monitors, and related consumables and nutrition products, as well as hemodialysis management services. It engages in the design and management of dialysis centers; and sale and service of healthy and natural drinks, as well as operates as an OEM supplier for beverage raw materials and concentrates. Hi-Clearance Inc. was founded in 1989 and is headquartered in New Taipei City, Taiwan.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.